Literature DB >> 22859505

The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development.

Sara Santambrogio1, Alessandra Ricca, Claudio Maderna, Alessandro Ieraci, Massimo Aureli, Sandro Sonnino, Willem Kulik, Patrizia Aimar, Luca Bonfanti, Sabata Martino, Angela Gritti.   

Abstract

We report a novel role for the lysosomal galactosylceramidase (GALC), which is defective in globoid cell leukodystrophy (GLD), in maintaining a functional post-natal subventricular zone (SVZ) neurogenic niche. We show that proliferation/self-renewal of neural stem cells (NSCs) and survival of their neuronal and oligodendroglial progeny are impaired in GALC-deficient mice. Using drugs to modulate inflammation and gene transfer to rescue GALC expression and activity, we show that lipid accumulation resulting from GALC deficiency acts as a cell-autonomous pathogenic stimulus in enzyme-deficient NSCs and progeny before upregulation of inflammatory markers, which later sustain a non-cell-autonomous dysfunction. Importantly, we provide evidence that supply of functional GALC provided by neonatal intracerebral transplantation of NSCs ameliorates the functional impairment in endogenous SVZ cells. Insights into the mechanism/s underlying GALC-mediated regulation of early post-natal neurogenic niches improve our understanding of the multi-component pathology of GLD. The occurrence of a restricted period of SVZ neurogenesis in infancy supports the implications of our study for the development of therapeutic strategies to treat this severe pediatric neurodegenerative disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859505     DOI: 10.1093/hmg/dds313

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.

Authors:  Nadav I Weinstock; Lawrence Wrabetz; M Laura Feltri; Daesung Shin
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.

Authors:  Gregory B Potter; Marta Santos; Muriel T Davisson; David H Rowitch; Dan L Marks; Ernesto R Bongarzone; Magdalena A Petryniak
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

3.  Isolation and Culture of Neural Stem/Progenitor Cells from the Postnatal Periventricular Region.

Authors:  Alessandra Ricca; Federica Cascino; Angela Gritti
Journal:  Methods Mol Biol       Date:  2022

4.  Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.

Authors:  Jing-Wen Yu; Yan-Hua Li; Guo-Bin Song; Jie-Zhong Yu; Chun-Yun Liu; Jian-Chun Liu; Hai-Fei Zhang; Wan-Fang Yang; Qing Wang; Ya-Ping Yan; Bao-Guo Xiao; Cun-Gen Ma
Journal:  J Mol Neurosci       Date:  2016-08-30       Impact factor: 3.444

5.  Region- and age-dependent alterations of glial-neuronal metabolic interactions correlate with CNS pathology in a mouse model of globoid cell leukodystrophy.

Authors:  Tore Wergeland Meisingset; Alessandra Ricca; Margherita Neri; Ursula Sonnewald; Angela Gritti
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

Review 6.  Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.

Authors:  M Laura Feltri; Nadav I Weinstock; Jacob Favret; Narayan Dhimal; Lawrence Wrabetz; Daesung Shin
Journal:  Glia       Date:  2021-04-14       Impact factor: 7.452

7.  Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.

Authors:  Elisabeth Mangiameli; Anna Cecchele; Francesco Morena; Francesca Sanvito; Vittoria Matafora; Angela Cattaneo; Lucrezia Della Volpe; Daniela Gnani; Marianna Paulis; Lucia Susani; Sabata Martino; Raffaella Di Micco; Angela Bachi; Angela Gritti
Journal:  Stem Cell Reports       Date:  2021-05-13       Impact factor: 7.765

8.  Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy.

Authors:  Alessandra Ricca; Nicole Rufo; Silvia Ungari; Francesco Morena; Sabata Martino; Wilem Kulik; Valeria Alberizzi; Alessandra Bolino; Francesca Bianchi; Ubaldo Del Carro; Alessandra Biffi; Angela Gritti
Journal:  Hum Mol Genet       Date:  2015-03-05       Impact factor: 6.150

9.  Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.

Authors:  Yedda Li; Christopher A Miller; Lauren K Shea; Xuntian Jiang; Miguel A Guzman; Randy J Chandler; Sai M Ramakrishnan; Stephanie N Smith; Charles P Venditti; Carole A Vogler; Daniel S Ory; Timothy J Ley; Mark S Sands
Journal:  Mol Ther       Date:  2021-01-01       Impact factor: 11.454

10.  Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin.

Authors:  Ryosuke Fukazawa; Hiroki Takeuchi; Nobuyuki Oka; Toko Shibuya; Norio Sakai; Akihiro Fujii
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.